Fibrinogen is not an additional risk factor of thromboembolic disease in factor V Leiden patients

被引：0
作者：
Billon, S
Escoffre-Barbe, M
Mercier, B
Abgrall, JF
Ferec, C
机构：
[1] CHU Morvan, Mol Genet Lab, F-29609 Brest, France
[2] CHU Morvan, Dept Hematol, Brest, France
[3] ETSBO, Ctr Biogenet, Brest, France
来源：
THROMBOSIS AND HAEMOSTASIS | 1999年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：659 / 660
页数：2
相关论文
共 5 条
  • [1] MUTATION IN BLOOD-COAGULATION FACTOR-V ASSOCIATED WITH RESISTANCE TO ACTIVATED PROTEIN-C
    BERTINA, RM
    KOELEMAN, BPC
    KOSTER, T
    ROSENDAAL, FR
    DIRVEN, RJ
    DERONDE, H
    VANDERVELDEN, PA
    REITSMA, PH
    [J]. NATURE, 1994, 369 (6475) : 64 - 67
  • [2] KIERKEGAARD A, 1980, ACTA CHIR SCAND, V146, P267
  • [3] KOSTER T, 1994, THROMB HAEMOSTASIS, V71, P719
  • [4] Factor V Leiden prevalence in venous thromboembolism patients
    Leroyer, C
    Mercier, B
    Escoffre, M
    Ferec, C
    Mottier, D
    [J]. CHEST, 1997, 111 (06) : 1603 - 1606
  • [5] LINKAGE DISEQUILIBRIUM ACROSS THE FIBRINOGEN LOCUS AS SHOWN BY 5 GENETIC POLYMORPHISMS, G/A(-455) (HAEIII), C/T(-148) (HINDIII/ALUI), T/G(+1689)(AVAII), AND BCLI (BETA-FIBRINOGEN) AND TAQI (ALPHA-FIBRINOGEN), AND THEIR DETECTION BY PCR
    THOMAS, A
    LAMLUM, H
    HUMPHRIES, S
    GREEN, F
    [J]. HUMAN MUTATION, 1994, 3 (01) : 79 - 81
1